Peapack-Gladstone Financial Corp’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.7M Buy
88,873
+482
+0.5% +$131K 0.3% 92
2025
Q4
$22.2M Buy
88,391
+1,481
+2% +$393K 0.28% 93
2025
Q3
$24.9M Buy
86,910
+686
+0.8% +$184K 0.32% 83
2025
Q2
$22.6M Sell
86,224
-3,389
-4% -$825K 0.32% 82
2025
Q1
$20.9M Sell
89,613
-3,704
-4% -$899K 0.31% 88
2024
Q4
$21.4M Buy
93,317
+387
+0.4% +$88.8K 0.31% 87
2024
Q3
$20.8M Buy
92,930
+484
+0.5% +$106K 0.3% 91
2024
Q2
$18.8M Sell
92,446
-1,166
-1% -$237K 0.29% 92
2024
Q1
$20.5M Buy
93,612
+741
+0.8% +$163K 0.32% 92
2023
Q4
$21.1M Buy
92,871
+445
+0.5% +$93.5K 0.36% 86
2023
Q3
$18.6M Sell
92,426
-14,371
-13% -$3.03M 0.34% 83
2023
Q2
$22.1M Sell
106,797
-310
-0.3% -$60.1K 0.39% 76
2023
Q1
$21.1M Sell
107,107
-9,977
-9% -$2.05M 0.4% 74
2022
Q4
$23.7M Sell
117,084
-2,473
-2% -$483K 0.47% 65
2022
Q3
$21M Buy
119,557
+2,154
+2% +$441K 0.43% 67
2022
Q2
$23.6M Sell
117,403
-483
-0.4% -$103K 0.54% 56
2022
Q1
$26.7M Sell
117,886
-2,370
-2% -$557K 0.52% 56
2021
Q4
$32.5M Sell
120,256
-1,264
-1% -$313K 0.61% 44
2021
Q3
$29.4M Sell
121,520
-1,689
-1% -$426K 0.61% 44
2021
Q2
$29.2M Sell
123,209
-2,399
-2% -$547K 0.7% 39
2021
Q1
$27.5M Buy
125,608
+823
+0.7% +$165K 0.71% 40
2020
Q4
$21.8M Buy
124,785
+1,268
+1% +$219K 0.65% 43
2020
Q3
$20M Buy
123,517
+9,374
+8% +$1.49M 0.73% 43
2020
Q2
$16.3M Buy
114,143
+285
+0.3% +$39.4K 0.64% 45
2020
Q1
$12.4M Sell
113,858
-261
-0.2% -$37.6K 0.58% 51
2019
Q4
$16.6M Buy
114,119
+39
+0% +$5.63K 0.67% 48
2019
Q3
$16.5M Buy
114,080
+2,435
+2% +$355K 0.71% 47
2019
Q2
$16.6M Buy
111,645
+1,276
+1% +$178K 0.72% 45
2019
Q1
$14.5M Sell
110,369
-620
-0.6% -$76.4K 0.66% 50
2018
Q4
$12M Sell
110,989
-2,747
-2% -$368K 0.62% 55
2018
Q3
$17M Buy
113,736
+791
+0.7% +$120K 0.83% 39
2018
Q2
$17.4M Buy
112,945
+2,805
+3% +$423K 0.91% 35
2018
Q1
$15.3M Buy
110,140
+3,301
+3% +$485K 0.83% 38
2017
Q4
$14.6M Buy
106,839
+558
+0.5% +$73.7K 0.79% 42
2017
Q3
$13.8M Buy
106,281
+1,647
+2% +$220K 0.79% 43
2017
Q2
$13.9M Sell
104,634
-3,585
-3% -$439K 0.83% 39
2017
Q1
$13.3M Buy
108,219
+31,605
+41% +$3.74M 0.82% 42
2016
Q4
$8.45M Buy
76,614
+93
+0.1% +$10.3K 0.55% 62
2016
Q3
$9.04M Buy
76,521
+9,778
+15% +$1.15M 0.6% 60
2016
Q2
$7.47M Buy
+66,743
New +$7.18M 0.52% 64

Other funds holding LH

Peapack-Gladstone Financial Corp's LH Position: Q1 2026 in Review

Peapack-Gladstone Financial Corp increased its Labcorp (LH) stake by 0.55% in Q1 2026, buying an estimated $131K and bringing the position to 88,873 shares worth $23.7M. The position accounts for 0.3% of the portfolio, ranked #92.

Peapack-Gladstone Financial Corp first reported a position in LH in Q2 2016 and has held it in 40 quarters since. The position peaked at $32.5M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Peapack-Gladstone Financial Corp held 88,873 shares of Labcorp worth $23.7M as of Q1 2026.
  • Peapack-Gladstone Financial Corp bought 482 Labcorp shares in Q1 2026, an estimated $131K.
  • Labcorp made up 0.3% of Peapack-Gladstone Financial Corp's portfolio in Q1 2026, its #92 holding.
  • Peapack-Gladstone Financial Corp first reported a position in Labcorp in Q2 2016 and has held it in 40 quarters since.
  • Peapack-Gladstone Financial Corp's Labcorp position peaked at $32.5M in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2026, filed 15 May 2026.